Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1984 1
1985 1
1986 1
1988 2
1989 1
1990 1
1991 1
1992 3
1993 2
1995 2
1996 2
1997 2
1999 2
2001 1
2002 3
2003 2
2004 7
2005 12
2006 9
2007 3
2008 6
2009 6
2010 12
2011 11
2012 17
2013 19
2014 20
2015 12
2016 14
2017 16
2018 26
2019 27
2020 24
2021 21
2022 24
2023 33
2024 25
2025 23
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Results by year

Filters applied: . Clear all
Page 1
NAT10 exacerbates acute renal inflammation by enhancing N4-acetylcytidine modification of the CCL2/CXCL1 axis.
Wang JN, Suo XG, Yu JT, Luo QC, Ji ML, Zhang MM, Zhu Q, Cheng XR, Hou C, Chen X, Wang F, Xu CH, Li C, Xie SS, Wei J, Zhang DF, Zhang XR, Wang ZJ, Dong YH, Zhu S, Peng LJ, Li XY, Chen HY, Xu T, Jin J, Chen FX, Meng XM. Wang JN, et al. Among authors: xu ch. Proc Natl Acad Sci U S A. 2025 Apr 29;122(17):e2418409122. doi: 10.1073/pnas.2418409122. Epub 2025 Apr 22. Proc Natl Acad Sci U S A. 2025. PMID: 40261924 Free PMC article.
Targeting Stat3 with conditional knockout or PROTAC technology alleviates renal injury by Limiting pyroptosis.
Ji ML, Wang JN, Wu MF, Xu CH, Zhang MM, Chang WB, Mao XF, Li C, Yu JT, Zhang DF, Suo XG, Diao SX, Ma NN, Chen Y, Hou R, Lu H, Xie SS, Dong YH, Zhu Q, Chen X, Xu T, Shao W, Jin J, Wen JG, Dong XW, Wang WB, Che JX, Meng XM. Ji ML, et al. Among authors: xu ch. EBioMedicine. 2025 Jun;116:105739. doi: 10.1016/j.ebiom.2025.105739. Epub 2025 May 8. EBioMedicine. 2025. PMID: 40344718 Free PMC article.
SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis.
Yu PC, Hou D, Chang B, Liu N, Xu CH, Chen X, Hu CL, Liu T, Wang X, Zhang Q, Liu P, Jiang Y, Fei MY, Zong LJ, Zhang JY, Liu H, Chen BY, Chen SB, Wang Y, Li ZJ, Li X, Deng CH, Ren YY, Zhao M, Jiang S, Wang R, Jin J, Yang S, Xue K, Shi J, Chang CK, Shen S, Wang Z, He PC, Chen Z, Chen SJ, Sun XJ, Wang L. Yu PC, et al. Among authors: xu ch. Dev Cell. 2024 Aug 5;59(15):1954-1971.e7. doi: 10.1016/j.devcel.2024.04.023. Epub 2024 May 21. Dev Cell. 2024. PMID: 38776924 Free article.
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.
Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, Chen X, He XY, He Y, Suo XG, Li C, Yu JT, Jiang L, Ni WJ, Jin J, Liu MM, Shao W, Yang C, Gong Q, Chen HY, Li J, Wu YG, Meng XM. Wang JN, et al. Among authors: xu ch. Sci Transl Med. 2022 Apr 13;14(640):eabk2709. doi: 10.1126/scitranslmed.abk2709. Epub 2022 Apr 13. Sci Transl Med. 2022. PMID: 35417191
Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia.
Hu CL, Chen BY, Li Z, Yang T, Xu CH, Yang R, Yu PC, Zhao J, Liu T, Liu N, Shan B, Zhang Q, Song J, Fei MY, Zong LJ, Zhang JY, Wu JC, Chen SB, Wang Y, Chang B, Hou D, Liu P, Jiang Y, Li X, Chen X, Deng CH, Ren YY, Wang R, Jin J, Xue K, Zhang Y, Du M, Shi J, Wu LY, Chang CK, Shen S, Chen Z, Chen SJ, Liu X, Sun XJ, Zheng M, Wang L. Hu CL, et al. Among authors: xu ch. Cell Res. 2022 Dec;32(12):1105-1123. doi: 10.1038/s41422-022-00735-6. Epub 2022 Oct 27. Cell Res. 2022. PMID: 36302855 Free PMC article.
The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.
Fei MY, Wang Y, Chang BH, Xue K, Dong F, Huang D, Li XY, Li ZJ, Hu CL, Liu P, Wu JC, Yu PC, Hong MH, Chen SB, Xu CH, Chen BY, Jiang YL, Liu N, Zhao C, Jin JC, Hou D, Chen XC, Ren YY, Deng CH, Zhang JY, Zong LJ, Wang RJ, Gao FF, Liu H, Zhang QL, Wu LY, Yan J, Shen S, Chang CK, Sun XJ, Wang L. Fei MY, et al. Among authors: xu ch. Blood. 2023 Sep 7;142(10):903-917. doi: 10.1182/blood.2022019537. Blood. 2023. PMID: 37319434 Free PMC article.
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma.
Li XY, Wu JC, Liu P, Li ZJ, Wang Y, Chen BY, Hu CL, Fei MY, Yu PC, Jiang YL, Xu CH, Chang BH, Chen XC, Zong LJ, Zhang JY, Fang Y, Sun XJ, Xue K, Wang L, Chen SB, Jiang SY, Gui AL, Yang L, Gu JJ, Yu BH, Zhang QL, Wang L. Li XY, et al. Among authors: xu ch. Leukemia. 2023 Jan;37(1):164-177. doi: 10.1038/s41375-022-01747-2. Epub 2022 Nov 9. Leukemia. 2023. PMID: 36352191 Free PMC article.
1,4-Bis[4-(dimethyl-silyl)phen-yl]benzene.
Fang L, Wang R, Chen LM, Xu CH, Li SH. Fang L, et al. Among authors: xu ch. Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 27;66(Pt 4):o971. doi: 10.1107/S1600536810010883. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21580771 Free PMC article.
370 results